GlobeNewswire by notified

Terranets tillträdande vd ingår avtal om att förvärva teckningsoptioner

Dela

PRESSMEDDELANDE
Lund, 26juli2022

Terranetsnyutnämnde vdMagnus Andersson har ingått avtal om att förvärvasamtliga av sina 2 500 000 berättigade teckningsoptioner i bolaget i samband med att han tillträder som ny vd. Optionerna tillhör det incitamentsprogram för ledning och anställda som årsstämman 2022 beslutade om i enlighet med styrelsens förslag.

Terranets styrelseordförande Anders Blom kommenterar optionsköpet:

”Det här är såklart en viktig signal som visar att tillträdande vd ser med långsiktighet på sin roll, ser potentialen i Terranet och känner ett genuint engagemang för det vi vill uppnå. Det är en bra utgångspunkt för att ta sig an vd-rollen”.

Tillträdande vd Magnus Andersson;

”Jag tror starkt på Terranet och marknaden man verkar inom, därför känns det naturligt att också ta en finansiell position i bolaget i samband med att jag kliver på som vd”.

Som tidigare meddelats tillträder Magnus Andersson sin roll som vd i Terranet senast den 1 september i år.

Tidigare i år meddelade Terranet också att bolagets CTO Nihat Küçük samt styrelseledamöterna Magnus Edman, Göran Janson och Karolina Bjurehed förvärvar teckningsoptioner i bolaget. Även dessa optionsköp sker inom ramen för de två incitamentsprogram som beslutades om vid årsstämman.

För mer information, vänligen kontakta:
Thomas Falkenberg, CFO
Tel: +46 703 360 346
E-mail: thomas.falkenberg@terranet.se

Denna information är sådan information som Terranet AB är skyldigt att offentliggöra enligt EU:s marknadsmissbruksförordning (MAR). Informationen lämnades, genom ovanstående kontaktpersons försorg, för offentliggörande den 26 juli 2022 kl. 08.00 CET

Om Terranet AB (publ)

Terranetsmål är att rädda liv i stadstrafiken.

Vi utvecklar banbrytande tekniklösningar för avancerat förarstöd (ADAS) och självkörande fordonsom skyddar utsatta trafikanter från att skadas på vägen.

Med hjälp aven unik, patenterad sensorteknologi laserskannarTerranetssystem BlincVision vägen och upptäcker objekt tio gånger snabbare och med högre precision än någon annan ADAS-lösning idag.

Terranet är baserat i Lundoch i Stuttgart, i hjärtat av den europeiska bilindustrin. Sedan 2017 är bolaget noterat på Nasdaq First North Premier Growth Market (Nasdaq: TERRNT-B).

Följ vår resa på www.terranet.se

Certified Adviser till Terranet är Mangold Fondkommission AB, 08-503 015 50, ca@mangold.se.

Bilaga

För att se det här innehållet från www.globenewswire.com måste du ge ditt medgivande sidans topp.
För att se det här innehållet från ml-eu.globenewswire.com måste du ge ditt medgivande sidans topp.

Om

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Följ GlobeNewswire by notified

Abonnera på våra pressmeddelanden. Endast mejladress behövs och den används bara här. Du kan avanmäla dig när som helst.

Senaste pressmeddelandena från GlobeNewswire by notified

Brookfield Reinsurance Completes Acquisition of AEL2.5.2024 22:10:00 CEST | Press release

BROOKFIELD, NEWS, May 02, 2024 (GLOBE NEWSWIRE) -- Brookfield Reinsurance (NYSE, TSX: BNRE, BNRE.A) and American Equity Investment Life Holding Company (NYSE: AEL) (“AEL”) today announced the completion of Brookfield Reinsurance’s acquisition of AEL in a cash and stock transaction valued at $56.50 per AEL share. AEL’s leading fixed annuity business bolsters Brookfield Reinsurance’s expanding insurance operations and increases its insurance assets under management to over $100 billion. Jon Bayer, Managing Partner at Brookfield Reinsurance said, “We are excited to welcome AEL to our organization as we continue to grow, diversify and scale our retirement services capabilities. AEL’s strong franchise and track record of serving policyholders and distribution partners, coupled with the scale of our existing platform and offerings, will position us well for the next phase of growth.” Brookfield Reinsurance expects to maintain AEL’s headquarters in Des Moines, Iowa, and its growth in the fixe

Fortinet Reports First Quarter 2024 Financial Results2.5.2024 22:05:43 CEST | Press release

First Quarter 2024 Highlights Total revenue of $1.35 billion, up 7% year over yearService revenue of $944 million, up 24% year over yearGAAP operating margin of 23.7%Non-GAAP operating margin of 28.5%1Cash flow from operations of $830 millionFree cash flow of $609 million1 SUNNYVALE, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Fortinet® (Nasdaq: FTNT), a global cybersecurity leader driving the convergence of networking and security, today announced financial results for the first quarter ended March 31, 2024. “We are diligently executing on our strategy announced six months ago to leverage our scale, go-to-market capabilities, customer-first focus, and engineering expertise to capitalize on the fast-growing Unified SASE and Security Operations markets while continuing to gain market share in Secure Networking,” said Ken Xie, Founder, Chairman and Chief Executive Officer of Fortinet. “We believe our Unified SASE offering is the most comprehensive in the industry and we are well-positioned

Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results2.5.2024 22:05:00 CEST | Press release

Reported $420.5 million in cash resources as of March 31, 2024, which when combined with certain anticipated regulatory milestone payments provides projected cash runway into 2H 2027Completion of rolling biologics license application (BLA) filing with the U.S. Food and Drug Administration (FDA) for zanidatamab as second-line treatment for biliary tract cancers (BTC) in the United States (U.S.) by our partner, Jazz PharmaceuticalsExpected initiation of a Phase 3 clinical trial for zanidatamab in the second half of 2024, for breast cancer patients who have progressed on trastuzumab deruxtecan (T-DXd), by our partner, Jazz Pharmaceuticals Two planned investigational new drug (IND) and foreign equivalent submissions in 2024 for ZW191 and ZW171Acceptance of an abstract for zanidatamab in BTC at the American Society of Clinical Oncology (ASCO) annual meeting submitted by our partner, Jazz PharmaceuticalsPresentation of five abstracts at the American Association for Cancer Research (AACR) ann

Willscot Mobile Mini Reports First Quarter 2024 Results2.5.2024 22:01:00 CEST | Press release

Solid Modular and Value-Added Products Demand Support Full Year 2024 Outlook PHOENIX, May 02, 2024 (GLOBE NEWSWIRE) -- WillScot Mobile Mini Holdings Corp. (“WillScot Mobile Mini” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary flexible space solutions, today announced first quarter 2024 results and provided an update on operations and the current market environment, including the following highlights: Q1 2024 Revenue increased 4% to $587 million and Income from continuing operations was $56 million. Income from operations included approximately $15 million of integration and transaction-related expenses. Adjusted EBITDA was flat year-over-year at $248 million.Generated Net cash provided by operating activities of $209 million and Free Cash Flow of $144 million, both up 40% year-over-year, with Free Cash Flow Margin of 24.5%, which increased by 660 basis points.Maintained leverage sequentially at 3.3x Net Debt to Adjusted EBITDA as of March 31, 2024, inside our target

Galapagos reports first quarter 2024 financial results2.5.2024 22:01:00 CEST | Press release

Advanced potentially best-in-class cell therapy and small molecule R&D pipeline comprising four clinical assets and >15 discovery programs in oncology and immunologyExecuted agreements with BridGene Biosciences and Thermo Fisher Scientific, and investment in Frontier MedicinesTransferred Jyseleca® business to Alfasigma S.p.A., freeing up resources to invest in growth areasGroup net revenues in the first quarter of €100 millionCash and current financial investments of €3.6 billion on 31 March 2024Reconfirmed 2024 cash burni guidance of €280 million to €320 million, not including potential business development opportunities Webcast presentationwith management on 3 May 2024,at 14:00 CET/8:00 am ET,www.glpg.com Mechelen, Belgium; 2 May 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) today announced its first quarter 2024 financial results and provided a business update and outlook for the remainder of 2024. “We are moving forward with a renewed focus, a diff

HiddenA line styled icon from Orion Icon Library.Eye